Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-8302

Single-particle
6.2 Å
EMD-8302 Deposition: 28/07/2016
Map released: 21/09/2016
Last modified: 14/02/2018
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-8302

HIV Clade B Env SOSIP ectodomain trimer from the Amsterdam Cohort Study patient AMC011 in complex with Fab from IgG PGV04

EMD-8302

Single-particle
6.2 Å
EMD-8302 Deposition: 28/07/2016
Map released: 21/09/2016
Last modified: 14/02/2018
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Human immunodeficiency virus 1
Sample: HIV Clade B Env SOSIP ectodomain trimer from the Amsterdam Cohort Study patient AMC011 in complex with Fab from IgG PGV04

Deposition Authors: Pallesen J, de Val N, Ozorowski G, Cottrell CA, Ward AB
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability.
PUBMED: 27841852
DOI: doi:10.1038/nmicrobiol.2016.199
ISSN: 2058-5276